6/05/2020 | Point of view
Impact of COVID-19 on Clinical Trials
Share
Many companies have paused or delayed scheduled clinical trials due to the Covid-19 emergency
Sarah Morgan, Liz O’Neil, and Karin Parks, our partners at Intouch Solutions, have analyzed the situation and discussed the challenges for the pharma industry to comply with protocol in existing trials and prevent that lifesaving treatments from reaching patients.
| Download the PoV here |
Read the full article at www.intouchsol.com
